Cantitate/Preț
Produs

Immunosuppression

Editat de Charles B. Taylor
en Limba Engleză Hardback – 28 sep 2009
Immunosuppression involves an act that reduces the activation or efficacy of the immune system. Some portions of the immune system itself have immuno-suppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse reaction to treatment of other conditions. Deliberately induced immunosuppression is generally done to prevent the body from rejecting an organ transplant, treating graft-versus-host disease after a bone marrow transplant, or for the treatment of auto-immune diseases such as rheumatoid arthritis or Crohn's disease. This is typically done using drugs, but may involve surgery (splenectomy), plasmapharesis, or radiation. A person who is undergoing immunosuppression, or whose immune system is weak for other reasons (for example, chemotherapy and HIV patients) is said to be immunocompromised. When an organ is transplanted, the immune system of the recipient will most likely recognise it as foreign tissue and attack it. The destruction of the organ will, if untreated, end in the death of the recipient. In the past, radiation therapy was used to decrease the strength of the immune system, but now immunosuppressant drugs are used to inhibit the reaction of the immune system. The downside is that with such a deactivated immune system, the body is very vulnerable to opportunistic infections, even those usually considered harmless. Also, prolonged use of immunosuppressants increases the risk of cancer. This book presents the latest research in the field.
Citește tot Restrânge

Preț: 74901 lei

Preț vechi: 101806 lei
-26% Nou

Puncte Express: 1124

Preț estimativ în valută:
14334 14874$ 11981£

Carte disponibilă

Livrare economică 24 februarie-10 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781606921029
ISBN-10: 1606921029
Pagini: 304
Ilustrații: tables & charts
Dimensiuni: 188 x 265 x 16 mm
Greutate: 0.88 kg
Editura: Nova Science Publishers Inc

Cuprins

Preface; Is there a future for costimulation blockade as a regulatory t- cell inducing therapy?; Strategies for T cell Depletion to Prevent Graft versus Host Disease; Leucocyte intracellular cytokines in lung transplant patients- a more physiological indicator of immunosuppression than plasma drug levels; Indications and management of m-TOR inhibitors after liver transplantation; Evolution of Immunosuppression in Liver Transplantation; The Role of Pharmacogenomics in Tailoring Immunosuppressive Therapy for Liver Transplant Recipients; Immunosuppression caused by photochemo-and photodynamic therapy: focus on photosensitiser photoproducts; Immunosuppressive therapy in adult to adult living- related liver transplantation; High-dose Immunosuppression with Autologous Stem Cell Transplantation in Severe Refractory Systemic Lupus Erythematosus; Experimental Approaches for Transplantation of Islets in the Absence of Immunosuppression; Oxidative Stress Peripheral Markers in Graves' Disease Ophthalmopathy Patients During Combined Immunosuppression; Index.